what is a glp-1 agonist medication Medications for Weight Loss Understand GLP-1/GIP Dual Agonist Tirzepatide

The opportunities in these indications can be assessed by deploying effective new product planning / opportunity assessment methodologies, including evaluating the following for each potential indication: Level of in-class / competitive activity Likelihood of technical and regulatory success (i.e., based on scientific rationale and regulatory precedent) Level and nature of unmet needs for new therapies in the disease area of interest Potential for GLP1-s to address these unmet needs Commercial attractiveness of market Potential speed to market Alignment with individual manufacturer portfolio / strategy / capabilities Conclusion Incretin mimetics have had an immense and growing impact on patient outcomes

45 , S1S2, (United States, 2022)

doi: 10.1126/scitranslmed.aaa9853 97 ShiLSunZSuWXuFXieDZhangQet al

Suction was applied and supplemental oxygen given

Data regarding the cancer risk associated with tirzepatide are limited in the published RCTs